Valuation: Stryker Corporation

Market Cap 127B 663B 110B 103B 93.92B 177B 12,160B 179B 1,212B 474B 6,092B 477B 467B 20,284B P/E 2026 *
25.7x
P/E 2027 * 22.4x
Enterprise Value 136B 710B 118B 111B 101B 189B 13,033B 192B 1,299B 508B 6,529B 511B 500B 21,740B EV / Sales 2026 *
4.99x
EV / Sales 2027 * 4.48x
Free-Float
94.9%
Yield 2026 *
1.09%
Yield 2027 * 1.16%
1 day-1.49%
1 week+1.22%
Current month+0.70%
1 month+11.62%
3 months+14.11%
6 months-5.04%
Current year-10.09%
1 week 88.62
Extreme 88.62
88.74
1 month 78.55
Extreme 78.55
90.08
Current year 69.77
Extreme 69.77
99.8
1 year 69.77
Extreme 69.77
107.34
3 years 64.71
Extreme 64.71
120.24
5 years 50.67
Extreme 50.666
120.24
10 years 44.61
Extreme 44.61
120.24
Manager TitleAgeSince
Chief Executive Officer 60 01/10/2012
Director of Finance/CFO 50 01/04/2025
President 49 01/01/2026
Director TitleAgeSince
Director/Board Member 82 01/01/1974
Director/Board Member 71 01/01/1984
Chairman 60 22/07/2014
Change 5-day change 1-year change 3-year change Capi.($)
-1.49%+1.22% - - 127B
-0.09%-4.18%-13.23%+19.23% 127B
+2.07%+0.45%-17.47%+2.59% 12.41B
-0.79%+1.50%+104.93%+155.37% 10.94B
-2.05%-7.70%-46.42%-68.85% 4.45B
+0.11%-0.45%-25.69%+42.67% 2.67B
-0.70%-3.11%-21.90%-14.22% 1.66B
+0.28%-3.92%-34.62%-72.80% 1.65B
-1.01%-3.26%-35.17%-36.93% 1.64B
Average -0.41%-2.61%-11.20%+3.38% 20.33B
Weighted average by Cap. -0.67%-3.47%-7.24%+23.25%

Financials

2026 *2027 *
Net sales 27.3B 142B 23.58B 22.18B 20.17B 37.94B 2,611B 38.54B 260B 102B 1,308B 102B 100B 4,356B 29.67B 155B 25.64B 24.11B 21.93B 41.25B 2,839B 41.9B 283B 111B 1,422B 111B 109B 4,736B
Net income 4.94B 25.76B 4.27B 4.02B 3.65B 6.87B 473B 6.98B 47.11B 18.44B 237B 18.55B 18.15B 789B 5.75B 29.96B 4.96B 4.67B 4.25B 7.99B 550B 8.11B 54.78B 21.44B 275B 21.57B 21.1B 917B
Net Debt 9.13B 47.57B 7.88B 7.41B 6.74B 12.68B 873B 12.89B 87B 34.05B 437B 34.26B 33.51B 1,456B 5.89B 30.7B 5.09B 4.78B 4.35B 8.18B 563B 8.31B 56.14B 21.97B 282B 22.11B 21.63B 940B
Logo Stryker Corporation
Stryker Corporation is one of the world's leaders in designing, manufacturing and marketing medical equipment and devices in the fields of medical surgery, neurotechnology and orthopaedics. Net sales break down by family of products as follows: - surgical equipment and neurotechnology products (62.3%): electric motorized surgical instruments, surgical navigation systems, endoscopy equipment, digital imaging systems, neurosurgery equipment, neurovascular devices, etc. The group also offers hospital beds, gurneys, stretchers, and emergency room equipment; - orthopedic implants (37.7%): joint prostheses, traumatology implants, micro-implants, orthopedic cement, orthobiology products, etc. The group also provides spinal implants. At the end of 2025, the group had 55 manufacturing sites worldwide. Net sales are distributed geographically as follows: the United States (75.7%), Europe/Middle East/Africa (12.7%), Asia/Pacific (8.6%) and other (3%).
Employees
56,000
Date Price Change Volume
13/08/26 BRL 88.74 -1.49% 34
11/08/26 BRL 90.08 +2.75% 42
Trader
Investor
Global
Quality
ESG MSCI
-
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
28
Last Close Price
331.37USD
Average target price
382.72USD
Spread / Average Target
+15.50%

Quarterly revenue - Rate of surprise